AccuRna
Hongo
About AccuRna
AccRna, Inc.'s aim is to promote therapeutic innovation in the form of nucleic acid medicine utilizing our robust DDS platform, providing effective treatment for refractory diseases for which there is currently no cure. Our dream is to deliver a “radical cure” to patients suffering from refractory diseases all over the world by safely and efficiently achieving the ultimate in the therapy utilizing nucleic acid.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Funding stage: M&A
- Last round: Series B (Dec 2019)
- Website: accurna.com
- Phone: +81-3-5803-2862
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/accurna-40117 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.